JP2025503961A5 - - Google Patents
Info
- Publication number
- JP2025503961A5 JP2025503961A5 JP2024544420A JP2024544420A JP2025503961A5 JP 2025503961 A5 JP2025503961 A5 JP 2025503961A5 JP 2024544420 A JP2024544420 A JP 2024544420A JP 2024544420 A JP2024544420 A JP 2024544420A JP 2025503961 A5 JP2025503961 A5 JP 2025503961A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- hydroxy
- dihydroxy
- weight
- hydroperoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303365P | 2022-01-26 | 2022-01-26 | |
| US202263303383P | 2022-01-26 | 2022-01-26 | |
| US63/303,383 | 2022-01-26 | ||
| US63/303,365 | 2022-01-26 | ||
| US202263304042P | 2022-01-28 | 2022-01-28 | |
| US63/304,042 | 2022-01-28 | ||
| US202263334065P | 2022-04-22 | 2022-04-22 | |
| US202263334071P | 2022-04-22 | 2022-04-22 | |
| US63/334,065 | 2022-04-22 | ||
| US63/334,071 | 2022-04-22 | ||
| US202263340304P | 2022-05-10 | 2022-05-10 | |
| US202263340292P | 2022-05-10 | 2022-05-10 | |
| US63/340,292 | 2022-05-10 | ||
| US63/340,304 | 2022-05-10 | ||
| US202263342509P | 2022-05-16 | 2022-05-16 | |
| US63/342,509 | 2022-05-16 | ||
| US202263348908P | 2022-06-03 | 2022-06-03 | |
| US63/348,908 | 2022-06-03 | ||
| PCT/US2023/011651 WO2023146984A1 (en) | 2022-01-26 | 2023-01-26 | Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503961A JP2025503961A (ja) | 2025-02-06 |
| JP2025503961A5 true JP2025503961A5 (enExample) | 2026-02-03 |
Family
ID=87472560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544420A Pending JP2025503961A (ja) | 2022-01-26 | 2023-01-26 | 脂肪酸のリンパ放出組成物並びにリンパ組み込み及び全身疾患治療のためのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240165066A1 (enExample) |
| EP (1) | EP4468884A4 (enExample) |
| JP (1) | JP2025503961A (enExample) |
| KR (1) | KR20240142470A (enExample) |
| AU (1) | AU2023213684A1 (enExample) |
| CA (1) | CA3248854A1 (enExample) |
| IL (1) | IL314467A (enExample) |
| MA (1) | MA66915A1 (enExample) |
| MX (1) | MX2024009147A (enExample) |
| WO (1) | WO2023146984A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX377553B (es) * | 2009-04-29 | 2025-03-10 | Amarin Pharma Inc | Composicion farmaceutica estable y metodos de uso de la misma. |
| WO2020245816A1 (en) | 2019-06-03 | 2020-12-10 | Migal Galilee Research Institute Ltd. | 5,6-dihete lactone for treatment of microvascular dysfunction |
| GB202400712D0 (en) * | 2024-01-18 | 2024-03-06 | Northwood Consultants Ltd | Anti-inflammatory composition and use |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3069322A (en) * | 1958-05-28 | 1962-12-18 | Bergstrom Sune | Pge and pgf |
| SE8604117D0 (sv) * | 1986-09-29 | 1986-09-29 | Kabivitrum Ab | Composition |
| US5262168A (en) * | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
| US5262437A (en) * | 1990-12-10 | 1993-11-16 | Allergan, Inc. | Homo-prostaglandin derivatives as ocular hypotensives |
| US6077525A (en) * | 1998-04-10 | 2000-06-20 | The George Washington University | Use of conjugated linoleic acids |
| US20060165735A1 (en) * | 2002-06-18 | 2006-07-27 | Abril Jesus R | Stable emulsions of oils in aqueous solutions and methods for producing same |
| TWI365716B (en) * | 2003-12-02 | 2012-06-11 | Suntory Holdings Ltd | Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same |
| US7893106B2 (en) * | 2004-11-19 | 2011-02-22 | Martek Biosciences, Corporation | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same |
| US20070042008A1 (en) * | 2005-08-18 | 2007-02-22 | Bodybio, Inc. | Compositions containing phosphatidylcholine and essential fatty acids |
| EP1983977A4 (en) * | 2006-01-31 | 2011-11-30 | Martek Biosciences Corp | OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| RU2470644C2 (ru) * | 2006-09-05 | 2012-12-27 | Кью.Пи. КОПЭРЕЙШН | Стабильная жировая эмульсия (варианты), способ ее получения, эмульгирующий агент и способы стабилизации простагландина и капель жира |
| WO2011060084A1 (en) * | 2009-11-10 | 2011-05-19 | MyCell Holdings Limited | Stabilized formulations of fatty acids |
| EP2664329A1 (de) * | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Ophthalmologisches Vehikelsystem |
| CA2894709C (en) * | 2012-12-24 | 2022-08-09 | Qualitas Health, Ltd. | Eicosapentaenoic acid (epa) formulations |
| CA2974495C (en) * | 2015-01-21 | 2023-05-23 | Mochida Pharmaceutical Co., Ltd. | .omega.-3 fatty acid self-emulsifying composition |
| KR102488648B1 (ko) * | 2015-01-21 | 2023-01-12 | 모치다 세이야쿠 가부시키가이샤 | ω3 지방산의 자기 유화 조성물 |
| JP6783891B2 (ja) * | 2019-04-10 | 2020-11-11 | 持田製薬株式会社 | ω３脂肪酸の自己乳化組成物 |
-
2023
- 2023-01-26 EP EP23747613.0A patent/EP4468884A4/en active Pending
- 2023-01-26 CA CA3248854A patent/CA3248854A1/en active Pending
- 2023-01-26 JP JP2024544420A patent/JP2025503961A/ja active Pending
- 2023-01-26 MA MA66915A patent/MA66915A1/fr unknown
- 2023-01-26 MX MX2024009147A patent/MX2024009147A/es unknown
- 2023-01-26 WO PCT/US2023/011651 patent/WO2023146984A1/en not_active Ceased
- 2023-01-26 KR KR1020247027934A patent/KR20240142470A/ko active Pending
- 2023-01-26 AU AU2023213684A patent/AU2023213684A1/en active Pending
- 2023-01-26 IL IL314467A patent/IL314467A/en unknown
- 2023-09-22 US US18/472,875 patent/US20240165066A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5946833B2 (ja) | ω３脂肪酸を濃縮する方法 | |
| JP5552313B2 (ja) | 脂質化合物 | |
| AU2013291680C9 (en) | Concentration of omega-3 polyunsaturated fatty acids in krill oil | |
| JP2015514083A5 (enExample) | ||
| KR100990814B1 (ko) | Ｄｈａ를 포함하는 지방산 조성물의 제조 방법 | |
| JP2014510166A5 (enExample) | ||
| JP2021004254A (ja) | 環境汚染物質を低減させた高度不飽和脂肪酸又は高度不飽和脂肪酸エチルエステル及びその製造方法 | |
| Tian et al. | Docosapentaenoic acid (22: 5n-3) downregulates mRNA expression of pro-inflammatory factors in LPS-activated murine macrophage like RAW264. 7 cells | |
| JP2012502090A5 (enExample) | ||
| JP2015500639A (ja) | ２０−炭素脂肪酸を含む組成物ならびにその製造方法および使用方法 | |
| JP2014512351A5 (enExample) | ||
| JP2021137035A5 (ja) | 高度不飽和脂肪酸のトリグリセリドを含む組成物 | |
| AU2020201555B2 (en) | Free polyunsaturated fatty acid-containing composition and manufacturing method therefor | |
| JP2017526623A5 (enExample) | ||
| JP2004217932A5 (enExample) | ||
| JP2025503961A (ja) | 脂肪酸のリンパ放出組成物並びにリンパ組み込み及び全身疾患治療のためのその使用 | |
| EP2217558A1 (en) | New dha derivatives and their use as medicaments | |
| JP2012514597A5 (enExample) | ||
| Yamamoto et al. | Lipase-catalyzed preparation of phospholipids containing n-3 polyunsaturated fatty acids from soy phospholipids | |
| CN118714935A (zh) | 淋巴释放的脂肪酸组合物以及其用于淋巴并入和全身性疾病治疗的用途 | |
| US20230068687A1 (en) | Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids | |
| Tian et al. | Bioconversion of docosapentaenoic acid in human cell lines, Caco-2, HepG2, and THP-1 | |
| JP2023514506A (ja) | 多価不飽和脂肪酸の固体中性アミノ酸塩の製造プロセス | |
| JP2021073195A5 (enExample) | ||
| JP2023511993A (ja) | ＰＵＦＡｓのマグネシウム塩およびそれを含有する組成物の生成プロセス |